[Bellantuono C, Migliarese G, Maggioni F, Imperadore G. (2007) Anridepressant drugs and breastfeeding. Recent Prog Med 98: 29-42.]Search in Google Scholar
[Chung TK, Lau TK, Yip AS, Chiu HF, Lee DT. (2001). Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes. Psychosom Med 63: 830-834.]Search in Google Scholar
[Da-Silva VA, Alterburg SP, Malheiros LR, Thomaz TG, Lindsey CJ. (1999). Postnatal development of rats exposed to fl uoxetine or venlafaxine during the third week of pregnancy. Braz J Med Biol Res 32: 93-98.]Search in Google Scholar
[DeSantis DT, Schmaltz LW. (1984). The mother-litter relationship in developmental rat studies: cannibalism vs caring. Dev Psychobiol 17: 255-6210.1002/dev.4201703066539261]Search in Google Scholar
[Dubovický M, Kovačovský P, Ujházy E, Navarová J, Brucknerová I, Mach M. (2008). Evaluation of developmental neurotoxicity: some important issues focused on neurobehavioral development Interdiscip Toxicol 1: 206-210.10.2478/v10102-010-0042-y299402421218116]Search in Google Scholar
[Dubovický M. (2010). Neurobehavioral manifestations of developmental impairment of the brain. Interdiscip Toxicol 3: 59-67.]Search in Google Scholar
[Evans J, Heron J, Francomb H, Oke S, Golding J. (2001). Cohort study of depressed mood during pregnancy and after childbirth. BMJ 323: 257-260.]Search in Google Scholar
[Favreliere S, Nourrisson A, Jaafari N, Pérault Pochat MC (2010). Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn. Encephale Suppl 2: D133-D138.]Search in Google Scholar
[Freeman MP. (2011). Antidepressant medication treatment during pregnancy: prevalence of use, clinical implications, and alternatives. J Clin Psychiatry 72: 977-978.]Search in Google Scholar
[Gentile S. (2005). SSRIs in pregnancy and lactation: emphasis on neurobehavioral outcome. CNS Drugs 19: 623-633.]Search in Google Scholar
[Melville JL, Gavin A, Gup Y, Fan MY, Katon WJ. (2010). Depressive disorders during pregnancy: prevalence and risk factors in a large urban sample. Obstet Gynecol. 116: 1064-1070.]Search in Google Scholar
[Morrison JL, Riggs KW, Rurak DW. (2005). Fluoxetine during pregnancy: impact on fetal development. Reprod Fertil Dev 17: 641-650.]Search in Google Scholar
[Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL. (2005). Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 293: 2372-2383.]Search in Google Scholar
[Nonacs R, Cohen LS. (2002). Depression during pregnancy: diagnosis and treatment options. J Clin Psychiatry 63: 24-30.]Search in Google Scholar
[Oberlander TF, Papsdorf M, Brain UM, Misri S, Ross C, Grunau RE. (2010). Prenatal effect of selective serotonin reuptake inhibitor antidepressants, serotonin, transporter promoter genotype (SLC6A4) and maternal mood on child behavior at 3 years of age. Arch Padiatr Adolesc Med 164: 444-451.]Search in Google Scholar
[OECD. (1995). Guideline for the testing of chemicals, Draft proposal for a new guideline 426, Developmental Neurotoxicity Study.]Search in Google Scholar
[Papakostas GI, Thase ME, Fava M, Nelson JC, Shelton RC. (2007). Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more eff ective than the selective serotonin reuptake inhibitors in treating major depression disorder? A meta-analysis of studies of newer agents. Biol Psychiatry 62: 1217-1227.]Search in Google Scholar
[Patil AS, Kuller JA, Rhee EH. (2011) Antidepressants in pregnancy: a review of commonly prescribed medications. Obstet Gynecol Surv 66: 777-8.10.1097/OGX.0b013e31823e0cbf22192462]Search in Google Scholar
[Pilar-Cuéllar F, Vidal R, Pazos A. (2012). Subchronic treatment with fluoxetine and the 5-HT(2A) antagonist ketanserin upregulates hippocampal BDNF and β-catenin in parallel with antidepressant-like eff ect. Br J Pharmacol. 165(4b): 1046-5710.1111/j.1476-5381.2011.01516.x334624721627639]Search in Google Scholar
[Rampono J, Simmer K, Ilett KF, Hackett LP, Doherty DA, Elliot R, Kok CH, Coenen A, Froman T. (2009). Placental transfer of SSRI and SNRI antidepressants and eff ects on the neonate. Pharmacopsychiatry 42: 95-100.]Search in Google Scholar
[Sumner SC, Fennell TR, Snyder RW, Taylor GF, Lewin AH. (2010). Distribution of carbon-14 labeled C60 ([14C]C60) in the pregnant and in the lactating dam and the eff ect of C60 exposure on the biochemical profi le of urine. J Appl Toxicol 30: 354-60.]Search in Google Scholar
[Tuccori M, Testi A, Antonioli L, Fomai M, Montagnani S, Ghisu N, Colucci R, Corona T, Blandizzi C, Del Tacca M. (2009). Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review. Clin Ther 31: 1426-1453.]Search in Google Scholar
[Weikop P, Kehr J, Scheel-Krüger J. (2007). Reciprocal eff ects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors. J. Psychopharmacol. 21: 795-804.]Search in Google Scholar
[Wellington K, Perry C. (2001). Venlafaxine extended-release: a review of its use in the management of major depression. CNS Drugs 15: 643-69.]Search in Google Scholar
